To contentTo navigationTo search
Logotype

Implantica announces Liselott Kilaas as new Chairman

07.05.2020
 | Other press releases

Implantica announces the election of Liselott Kilaas as Chairman of the Board of Directors at the Company’s EGM held 29. April 2020.

TypeError: Cannot read property 'url' of undefined

Mrs. Kilaas brings 20 years of top management experience and an extensive background in leading healthcare and medtech companies, having served as CEO of Aleris Group, the largest healthcare corporation in Scandinavia from 2013-2017. She is currently the Chairman of the medtech / healthcare companies Coala Life AB and Avonova AB and sits on the boards of many high profile companies including Ambea AB, Peab AB, Norsk Hydro and Orkla ASA.

Implantica is pleased to welcome Mrs. Kilaas to the role of Chairman, highly values her extensive experience and is confident her strategic guidance will help to position the company for success.

About Implantica

Implantica is a privately held medtech company dedicated to bringing advanced technology into the body. Implantica’s first product, RefluxStop™, will potentially create a paradigm shift in anti-reflux surgery as supported by the successful clinical trial results. Implantica’s wireless energizing platform, developed for eHealth Smart Medical Implants, is designed to make previously impracticable medical implants possible with the ability to power remote controlled implants wirelessly through intact skin. In addition, Implantica has developed an eHealth platform to be initially used in combination with upcoming eHealth smart implants and later as a stand-alone eHealth monitoring device, e-InVivo™. This is designed to collect data from inside the body and transfer the data to external devices or directly to the caregiver. e-InVivo™ is designed to monitor a broad range of health parameters and provide diagnostic information with early detection of diseases as well as control treatment from inside the body.


This website uses cookies to provide the best possible user experience. If you continue without making any changes you allow this. Read more about cookies here